Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Applied Therapeutics
Biotech
Applied lays off 46% of workforce as rare disease plans stall
Applied Therapeutics is laying off almost half its workforce to conserve its remaining cash.
James Waldron
Nov 20, 2025 9:10am
Analysts skeptical Applied can bring rare disease drug to market
Nov 14, 2025 5:25am
Applied Tx's stock drops on non-update for rare disease asset
Sep 29, 2025 10:57am
BMS banks on Wall Street vet for strategy— Chutes & Ladders
Jun 20, 2025 8:30am
Applied's rare disease drug suffers another phase 3 failure
May 19, 2025 7:20am
Applied CEO steps down in wake of FDA rejection, warning letter
Dec 20, 2024 12:51pm
